The U.S. pharmaceutical and biotechnology industry is entering a period of strong growth, but a shortage of skilled professionals could challenge the sector’s ability to expand. According to recent workforce analysis, demand for specialized talent across engineering, data science, cybersecurity, and product management roles continues to rise rapidly, while the supply of qualified professionals is struggling to keep pace.
The engineering workforce in the U.S. pharma and biotech sector is expected to grow by nearly 15% over the next five years. This growth is largely driven by advancements in biomanufacturing and process technologies. States such as North Carolina and Massachusetts are emerging as major engineering hubs as universities and research institutions continue to supply skilled graduates.
At the same time, demand for data and artificial intelligence specialists has increased by more than 25% in the past year. Companies are increasingly using data analytics to support drug discovery, clinical research, and market analysis. Regions such as California and Massachusetts benefit from strong academic ecosystems that include institutions like Massachusetts Institute of Technology and Stanford University, which continue to produce highly skilled graduates for the industry.
Cybersecurity has also become a major priority for pharmaceutical and biotech companies as operations become more digital. Demand for cybersecurity professionals is projected to grow by around 20% annually. States such as Maryland and Virginia are seeing increased hiring activity due to their proximity to federal research agencies and regulatory bodies.
Product management is another area experiencing rising demand. Industry estimates suggest a potential shortage of nearly 10,000 product managers by 2025 as companies seek to improve product development and commercialization strategies.
Although U.S. universities produce about 50,000 graduates each year in relevant fields, this number is still not enough to meet industry demand. Overall, the sector could face a shortage of around 40,000 skilled professionals by 2025. Many employers also report that graduates often lack practical experience, creating a mismatch between available talent and job requirements.
Salary benchmarks across key roles reflect this growing demand. Entry-level data scientists earn around $85,000 annually, while experienced professionals can earn up to $130,000. Product managers command even higher salaries, with senior professionals earning up to $140,000. Engineering and cybersecurity roles also offer competitive salaries, reflecting their importance to industry operations.
Hiring trends are also shifting. Around 60% of companies now prefer hybrid or remote work models to attract talent, particularly in cities where living costs are high. This change is helping companies recruit from a broader talent pool beyond traditional biotech hubs.
However, the industry is also facing human resource challenges. Employee turnover rates average around 15% annually, creating additional pressure on companies to retain skilled workers. Organizations are investing in training programs and career development initiatives to strengthen retention and help employees build new skills.
Automation is expected to reshape the workforce by 2030. Nearly 40% of current roles may be affected by automation, particularly in manufacturing, quality control, and data processing. Rather than replacing workers, automation is expected to support employees by handling repetitive tasks while allowing professionals to focus on research, innovation, and strategic work.
Looking ahead, several future roles are expected to grow in importance, including data science analysts, clinical trial managers, digital health specialists, and biomanufacturing engineers. These roles require a mix of technical knowledge, data skills, and project management capabilities.
Major pharmaceutical and biotech companies continue to drive hiring activity across the sector. Industry leaders such as Pfizer, Johnson & Johnson, and Merck remain key employers, while biotechnology firms like Moderna and Amgen are expanding rapidly and competing for specialized talent.
Academic institutions also play a critical role in supporting the talent pipeline. Universities such as Johns Hopkins University and University of California, San Francisco continue to contribute to the industry through research programs and partnerships with pharmaceutical companies.
With healthcare demand increasing and innovation accelerating, the U.S. pharma and biotech industry is expected to create more than 500,000 new jobs by 2030. To support this growth, companies will need to focus on workforce development, training, and strategic hiring to close the growing talent gap and sustain long-term industry expansion.
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek